EasyVoid™

We measure blood pressure to understand our heart, but how well do we know about our bladder? Nearly 45% of people worldwide suffer from lower urinary tract symptoms (LUTS), yet fewer than 3% ever receive diagnostic testing. EasyVoid™ is here to close this diagnostic gap.

The Bottleneck

It turns out the current gold standard for bladder function testing is also its greatest obstacle. Traditional uroflowmetry requires patients to hold their urine for hours, travel to a clinic, and urinate into a large, expensive scale under supervision. Each test can take up to 30 minutes—and despite the effort, over 60% of tests fail. This bottleneck limits access to diagnosis and delays care for millions living with lower urinary tract symptoms.

An infographic titled "A Clear Bottleneck in Urology Diagnostics" comparing clinical and patient pain points. On the left, under Clinical Pain Points, it highlights that tests take 20-30 minutes, have a 63% failure rate, and are performed on 1 machine with low throughput. On the right, under Patient Pain Points, it mentions patients need to hold urine for 2 hours, urinate in a supervised setting, and 58% resist the test.

The Science

A scientific chart comparing urine flow rates between EasyVoid and Standard methods across four different uroflow patterns: Bell-shape, Bell-with-tail, Interrupted, and Plateau, each with line graphs showing data over time.

Behind every breakthrough is a simple idea. We asked how physics could make measuring urine flow rate smarter.
Using the Coandă effect—the natural tendency of a fluid to follow curved surfaces—EasyVoid™ captures urine flow dynamics in real time, converting them into accurate digital readouts. It’s science made seamless, turning motion into insight.

Quick facts:

✓ faithfully reproduce urine flow pattern.

✓ strong correlation with clinical gold standards. (R=0.85-0.99)

✓ 91% agreement rate in recognizing abnormal urine pattern.

Read our preprint! (Under Review in IEEE JTEHM)

Patent: PCT/US2025/034459; TW Appl No. 114123217

FITI 1st place winner
Group of seven people standing on stage during an award ceremony, holding a large check for 1,000,000 New Taiwan Dollars, with a green backdrop that reads 'FROM IP TO IPO PROGRAM' and related text in Chinese.

Our product received First Prize in the 2025 FITI Program, Taiwan’s largest med-tech startup competition, earning NT$1 million in startup funding.

Awards & Recognition

Supporters & Partners

  • Logo for Spark Taiwan with colorful squares above the word 'SPARK' in large red letters and 'TAIWAN' below in smaller red letters.

    SPARK Taiwan Program

  • FITI

    FITI Innovation Program

  • Stacked rocks on a pebbled riverbank

    Join us in advancing the future of diagnostics.